EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $269,263 | -47.8% | 13,851 | -23.8% | 0.17% | -43.0% |
| Q1 2023 | $515,710 | +0.2% | 18,178 | +3.2% | 0.30% | -2.3% |
| Q4 2022 | $514,682 | +12.6% | 17,608 | +1.7% | 0.31% | -2.8% |
| Q3 2022 | $457,000 | -44.7% | 17,308 | -7.0% | 0.32% | -43.4% |
| Q2 2022 | $827,000 | -10.2% | 18,604 | 0.0% | 0.56% | +7.3% |
| Q1 2022 | $921,000 | +2.0% | 18,604 | +4.9% | 0.52% | +6.8% |
| Q4 2021 | $903,000 | -8.8% | 17,742 | 0.0% | 0.49% | -16.0% |
| Q3 2021 | $990,000 | – | 17,742 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |